Asia Pacific Prosthetic Heart Valve Market, by Type (Mechanical Heart Valve, Transcatheter Heart Valves and Tissue Heart Valve) By Country - Asia Pacific Forecast to 2021
In cases of the malfunctioning of any of the four natural valves, a surgery can be performed to replace it with a prosthetic valve. A prosthetic heart valve is an artificial valve placed in the heart of a patient suffering from valvular heart disease. Heart valve disease can occur in any single valve or a combination of the four valves; however, the diseases of the aortic and mitral valves are the most common. A prosthetic heart valve can be either mechanical valve or tissue (bio-prosthetic) valve.
The purpose of this report is to cover the description, definition and forecast of the Asia Pacific Prosthetic Heart Valve market. It involves deep dive analysis of market segmentation, which comprises of products and country. The Asia Pacific prosthetic heart valve market was estimated to grow from USD 454.4 million in 2015 to USD 829.6 million in 2021, at a CAGR of 10.6%.
Rise in aging population, technological advancements and increased prevalence of heart valve disease are some of the factors influencing the growth of the prosthetic heart valve market.
By type, the Asia Pacific Prosthetic Heart Valve market is divided into Mechanical heart valve, Transcatheter heart valves and Tissue heart valve. The Transcatheter heart valves is growing at a CAGR of 11.4% of the Asia Pacific Prosthetic Heart Valve market in 2015.
In-depth market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports, and interviews with industry experts and key opinion leaders, such as CEOs, directors, and marketing executives.
The major players in this market include St. Jude Medical, Inc. (U.S.), Sorin S.p.A (Italy), Medtronic (Republic of Ireland), Abbot Laboratories (U.S), Edwards Lifesciences Corporation (U.S.) and Meril Life Sciences Pvt. Ltd. (India), among others. These companies have adopted various strategies, such as mergers & acquisitions and partnerships, among others, to achieve growth in the Asia Pacific Prosthetic Heart Valve market.
Scope of the Report:
This report categorizes the Asia Pacific market for Asia Pacific Prosthetic Heart Valve on the basis of type and Country.
Market Segmentation, by Type:
Based on type, the Asia Pacific Asia Pacific Prosthetic Heart Valve market is segmented into mechanical heart valves, tissue heart valves, and transcatheter heart valve.
Market Segmentation, by Country:
- Republic of Korea
- New Zealand
- New Zealand
- Prosthetic heart valve companies
- Government and Research Organizations
- Private Medical Offices
- Emergency Care Units
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company mapped at the country and subsegment level
- End-user adoption rate analysis of products (segment and country-wise)
- Comprehensive coverage of product approvals, volume data, pipeline products, and product recalls
- Brand/product perception matrix
Asian Cardiac Monitoring Devices Market
There are 6 segments such as Cardiac Rhythm Management Devices, Electrocardiogram, Holter Monitors, Event Monitors, Implantable Loop Recorder and Cardiac Output Monitoring Devices.
Asia Pacific Cardiac Output Monitoring Devices Market Research Report
There are sub segments- invasive, non-invasive and minimally invasive.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement